Advanced Cell Technology Announces Creation Of Human Embryonic Stem Cell Lines Without The Destruction Of Embryos
Advanced Cell Technology, Inc. (OTC Bulletin Board: ACTC) together with colleagues announced today the development of five human embryonic stem cell (hESC) lines without the destruction of embryos. These new results have the potential to end the ethical debate surrounding the use of embryos to derive stem cells. In fact, the NIH report to the President refers to this technology as one of the viable alternatives to the destruction of embryos.
More: continued here